Daily intelligence on orthopaedic device companies, FDA 510(k) clearances, M&A activity, earnings, and strategic moves across the global medtech landscape.
EXECUTIVE SUMMARY Aclarion Expands CLARITY Multicenter Trial Site to University of Arizona – Phoenix: Aclarion added the University of Arizona College of Medicine – Phoenix as a key clinical investigative site for its pivotal CLARITY clinical trial, evaluating...
EXECUTIVE SUMMARY JBJS Clinical Analysis Establishes Definitive Fusion Indications for Recurrent Lumbar Disc Herniation: A clinical review published in JBJS (The Journal of Bone and Joint Surgery) outlines clear criteria for performing instrumented lumbar fusion over repeat...
EXECUTIVE SUMMARY Nanochon Receives Regulatory Clearance to Initiate First-in-Human Clinical Trial for 3D-Printed Chondrograft™: MedTech regenerative developer Nanochon received Ministry of Health approval to begin first-in-human clinical evaluation of its 3D-printed...
EXECUTIVE SUMMARY Smith+Nephew Launches FLOW FLEXTEND™ COBLATION™ Wand for Hip Arthroscopy: Smith+Nephew announced the commercial release of the FLOW FLEXTEND™ COBLATION™ Wand, featuring articulating radiofrequency plasma technology designed to improve...
EXECUTIVE SUMMARY JAAOS Multicenter Study Demonstrates Significant Reduction in Acromial Fractures with 3D Preoperative Planning: A large 17-year retrospective cohort study of 2,380 patients published in JAAOS demonstrates that routine 3D virtual surgical planning and modern...
EXECUTIVE SUMMARY Medartis Launches TITAN Nail System for Intramedullary Hand Fracture Fixation in the US: Medartis announced the official commercial US rollout of its TITAN Nail System, introducing an intramedullary alternative to traditional plate-and-screw constructs for...
EXECUTIVE SUMMARY Orthofix Raises Full-Year 2026 Guidance on Strong Limb Reconstruction and Spine Traction: Orthofix Medical raised full-year net sales guidance to $845M–$855M and adjusted EBITDA to $95M–$98M, propelled by double-digit growth in Limb Reconstruction...
EXECUTIVE SUMMARY Spineart Obtains Landmark FDA Approval for BAGUERA® C Cervical Disc Across 1 and 2 Levels: Spineart received FDA approval for its BAGUERA® C cervical disc replacement system supported by two US RCTs (600 patients) and a 10-year follow-up study...
Curated for Orthogate.org Members EXECUTIVE SUMMARY Eminent Spine Publishes Clinical Evidence on World's First FDA-Cleared 3D Printed Titanium Pedicle Screw: Clinical study results released by Eminent Spine confirm zero hardware complications or bone-implant interface failures...